Physician profile
Donald Nikchvich
NPI 1669504627
$34,467.55
in general payments reported to CMS, 2019-2025
5 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $4,600 · 2021: $9,347 · 2022: $4,327 · 2023: $429 · 2024: $2,124 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,282 · Travel and Lodging: $2,058 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $1,699 · Gift: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,282.09 |
| Travel and Lodging | $2,057.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $1,698.80 |
| Gift | $447.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neocis INC. | $18,756.10 | 2020-2025 | |
| Straumann USA LLC | $15,376.24 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $163.98 | 2023-2024 | Geistlich Bio-Gide, Bio-Gide |
| Nobel Biocare USA | $151.40 | 2019-2023 | Nobelactive |
| Pacira Pharmaceuticals Incorporated | $19.83 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Nikchvich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.